[1] Kacała A, Dorochowicz M, Matus I, et al. Hepatic hemangioma: review of imaging and therapeutic strategies[J]. Medicina (Kaunas), 2024, 60(3):449. [2] LeGout J D, Bolan C W, Bowman A W, et al. Focal nodular hyperplasia and focal nodular hyperplasia-like lesions[J]. Radiographics, 2022, 42(4):1043-1061. [3] Hwang S Y, Danpanichkul P, Agopian V, et al. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment[J]. Clin Mol Hepatol, 2025, 31(Suppl):S228-S254. [4] Singh S P, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma[J]. J Clin Exp Hepatol, 2025, 15(2):102446. [5] Alexander H R Jr, Devi-Chou V. Hepatic perfusion for diffuse metastatic cancer to the liver: open and percutaneous techniques[J]. Hematol Oncol Clin North Am, 2025, 39(1):177-190. [6] Fan P L, Chu J, Wang Q, et al. The clinical value of dual-energy computed tomography and diffusion-weighted imaging in the context of liver cancer: a narrative review[J]. J Clin Ultrasound, 2022, 50(6):862-868. [7] Ginocchio L A, Jaglan S, Tong A, et al. Accelerated diffusion-weighted magnetic resonance imaging of the liver at 1.5 T with deep learning-based image reconstruction: Impact on image quality and lesion detection[J]. J Comput Assist Tomogr, 2024, 48(6):853-858. [8] Wang Q, Yu G, Qiu J, et al. Application of intravoxel incoherent motion in clinical liver imaging: a literature review[J]. J Magn Reson Imaging, 2024, 60(2):417-440. [9] Meyer H J, Potratz J, Jechorek D, et al. Association between diffusion-weighted imaging and tumor matrix in liver cancer: a cross-sectional study[J]. Transl Cancer Res, 2025, 14(3):1764-1771. [10] Liu S, Lin Y, Situ W, et al. Comparisons of integrated slice-specific dynamic shimming EPI and single-shot EPI diffusion-weighted imaging of the liver[J]. Eur J Radiol, 2025, 183:111942. [11] Podgórska J, Pasicz K, Skrzyński W, et al. Perfusion-diffusion ratio: a new IVIM approach in differentiating solid benign and malignant primary lesions of the liver[J]. Biomed Res Int, 2022, 2022:2957759. [12] Song Q, Guo Y, Yao X, et al. Comparative study of evaluating the microcirculatory function status of primary small HCC between the CE (DCE-MRI) and Non-CE (IVIM-DWI) MR Perfusion Imaging[J]. Abdom Radiol (NY), 2021, 46(6):2575-2583. [13] Yang Y, Zhou Z, Li Y. MRI-based deep learning model for differentiation of hepatic hemangioma and hepatoblastoma in early infancy[J]. Eur J Pediatr, 2023, 182(10):4365-4368. [14] Jia C, Liu G, Wang X, et al. Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study[J]. Jpn J Radiol, 2021, 39(11):1059-1068. [15] Gu K, Jeon T Y, Yoo S Y, Kim JH. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors[J]. Eur Radiol, 2021, 31(1):283-291. [16] Marin D, Brancatelli G, Federle MP, et al. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media[J]. Clin Radiol, 2008, 63(5):577-585. [17] Matsuda K, Ueno A, Tsuzaki J, et al. Vessels encapsulating tumor clusters contribute to the intratumor heterogeneity of HCC on Gd-EOB-DTPA-enhanced MRI[J]. Hepatol Commun, 2024, 9(1):e0593. [18] Zhang L, Yu X, Wei W, et al. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology[J]. Eur Radiol, 2020, 30(10):5327-5336. [19] Liu B, Zeng Q, Huang J, et al. IVIM using convolutional neural networks predicts microvascular invasion in HCC[J]. Eur Radiol, 2022, 32(10):7185-7195. [20] Yang C, Wei X Q, Zheng J, et al. A correlative study between IVIM-DWI parameters and VEGF and MMPs expression in hepatocellular carcinoma[J]. Quant Imaging Med Surg, 2023, 13(3):1887-1898. |